-
October 13, 2016 Type 2 Diabetes: Boehringer Ingelheim India and Lupin Announce Strategic Co-marketing Agreement
-
October 6, 2016 Lupin and Monosol Rx announce licensing agreement for multiple pediatric-focused products
-
September 29, 2016 Lupin Receives FDA Approval for Generic Namenda XR® Capsules
-
September 6, 2016 Lupin Receives Tentative Approval for Generic Rapaflo® Capsules
-
September 1, 2016 Lupin Receives Tentative Approval for Generic Zithromax® Oral Suspension
-
August 26, 2016 Lupin Receives Tentative Approval for Generic Paxil CR® Tablets
-
August 24, 2016 Lupin Receives FDA Approval for Generic Zyvox® Tablets
-
August 22, 2016 Lupin Receives Approval for Acotiamide Tablets to Treat Functional Dyspepsia
-
August 17, 2016 Lupin Receives FDA Approval for Potassium Chloride Extended-Release Capsules
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications